Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02568501 · ClinicalTrials.gov registry record · Phase 3

Behavioral Economic Incentives to Improve Glycemic Control Among Adolescents and Young Adults

A Phase 3 study, sponsored by University of Pennsylvania.

Completed
Registry status
Phase 3
Development phase
90
Enrollment target

NCT02568501: Completed Phase 3 study, sponsored by University of Pennsylvania.

NCT02568501 is a Phase 3 study that has completed, run by University of Pennsylvania. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02568501, a Phase 3 study, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
Phase 3
Development phase
90 participants
Enrollment target

Study Summary

In this study the investigators will compare a novel approach using daily financial incentives and a tiered sponsor network to motivate adolescents and young adults with type 1 diabetes to improve glycemic control.

Interventions

  • BEHAVIORAL Financial incentive
  • BEHAVIORAL Daily feedback

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2016-01
Est. Completion 2016-11
Phase Phase 3

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT02568501

The ClinicalTrials.gov registry entry for NCT02568501 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Financial incentive is the first listed.

NCT02568501 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02568501 about?

NCT02568501 is a clinical study titled "Behavioral Economic Incentives to Improve Glycemic Control Among Adolescents and Young Adults". In this study the investigators will compare a novel approach using daily financial incentives and a tiered sponsor network to motivate adolescents and young adults with type 1 diabetes to improve glycemic control.

What is the current status of trial NCT02568501?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 90 participants. The study started on 2016-01. Estimated completion is 2016-11.

What interventions are being tested in trial NCT02568501?

The interventions under investigation include: Financial incentive (BEHAVIORAL), Daily feedback (BEHAVIORAL).

Who is sponsoring clinical trial NCT02568501?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.